Trial Profile
Efficacy and Safety Comparison of Sitagliptin and Glimepiride in Elderly Japanese Patients With Type 2 Diabetes.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms START-J
- 14 Jun 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan. (UMIN000004721)
- 25 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan (UMIN000004047).
- 16 Mar 2012 Planned End Date changed from 1 Mar 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.